Sign in
CompletedNo phase

New Moms Mood Tracking & Wellbeing

Key facts

Who runs it
University of California, Los Angeles
Where
Los Angeles, United StatesSee the site
Trial code
Status
Completed
People taking part
166 people enrolled
Started
15 Apr 2021
Ended
1 Apr 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Online therapy with coaching within STAND
  • Clinical care within STAND
  • Perinatal Psychiatric Care
Record updated
31 July 2024

Who can take part

Age
18 years to 65 years
Sex
Women only
Healthy volunteers
Cannot take part
Show the full registry criteria (14)Hide the full registry criteria

Who can take part

  • Women who are between week 28 of their pregnancy and 6 months postpartum and are receiving care at a UCLA OB-GYN clinic
  • Fluent in English
  • Current endorsement of moderate or higher depression on the Edinburgh Postnatal Depression Scale (EPDS, => 11 sum score), administered by the treating OB-GYN physician or study staff
  • Not currently in individual treatment for a behavioral or emotional problem (e.g., anxiety, depression)
  • Willingness to follow study procedures
  • Willingness to participate in treatment through the study and follow all study procedures, including provide HIPAA Authorization for research
  • Has access to the internet via mobile or desktop device

Who cannot take part

  • Are currently receiving treatment by a therapist or a psychiatrist
  • Current substance use disorder that interferes with treatment: specifically, patients meeting diagnostic criteria for Substance Use Disorder (SUD) will be eligible for inclusion only if they are able to attend sessions while not under the influence of that substance, with the exception of individuals abusing opiates or freebase cocaine, who will be excluded
  • Neurological conditions
  • Severe uncontrolled medical conditions (e.g., anorexia nervosa, cardiac conditions requiring continuous monitoring)
  • Cognitive impairment (e.g., developmental disability, dementia)
  • Unstable suicidality (e.g., 2 or more suicide attempts or self-injurious behaviors resulting in hospitalization in the last 6 months, combined with high ratings on self-reported negative urgency)
  • Principal diagnosis of psychosis unrelated to depression (unipolar or bipolar)

Where in United States

  • University of California Los Angeles (UCLA).Los Angeles, United States

About the trial

What the trial wants to find out

New moms can be at risk for perinatal depression (PND). The New Moms Mood Tracking and Wellbeing study is investigating mood changes, risk factors for depression and anxiety and treatment response around the time of delivery. Participants will be asked to complete three sets of online surveys between week 28 gestation and week 20 after delivery, in addition to downloading an app to collect data using their smartphone sensors and brief symptom surveys every other week. Women with elevated symptoms will be eligible to participate in a treatment study. Women who are eligible for the treatment study will be randomized to one of two conditions - Perinatal Psychiatric Care or Screening and Treatment for Anxiety and Depression (STAND). In Perinatal Psychiatric Care, participants will receive appointments with psychiatry clinicians for medication management and supportive therapy. In STAND, participants will be allocated to Online therapy with Coaching or Clinical Care, which includes both psychotherapy and psychiatry appointments. Treatment can last up to 6 months and there will be treatment related assessments for the duration of the 6 months, in addition to brief symptom surveys on a regular basis. Therefore, participation can last between 24 and 52 weeks, as both time of delivery and treatment enrollment timepoint cannot be scheduled in advance.

The 2 groups in the trial

  • Perinatal Psychiatric CareOther group

    This treatment condition is modelled after the psychiatry-delivered treatment usually provided at the Maternal Outpatient Mental Health Services (MOMS) Clinic associated with the UCLA Westwood OB-GYN Clinic and Department of Psychiatry.

  • Screening and Treatment of Anxiety and Depression (STAND)Treatment being tested

    This treatment condition provides access to a system of care, in which type of treatment is allocated based on presenting symptomatology. Participants will learn their allocation from study staff or participants will create a secure account through STAND to learn about their allocation through the STAND online dashboard. Through their STAND online dashboard, they could also have access to their CAT-MH results over time from the start of treatment.

    Treatment: Online therapy with coaching within STAND and Clinical care within STAND

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Perinatal Mood Tracking and Treatment
Publications
Record updated
31 July 2024